Pulished Date October, 2018
ID: 2700
Share on
Share on

Non-Invasive Prenatal Testing Market By Instruments (Ultrasound, NGS, PCR, Microarray), Method (FCMB, Cf-DNA), By Application (Trisomy, Microdeletion, Genetics, Rh Factor), By End User (Hospital, Diagnostic Labs) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023

Pulished: October, 2018
ID: 2700
Pages: 176

Market Overview:

Non-Invasive Prenatal Testing (NIPT) is a new type of genetic test that screens for inherited diseases and birth defects. It generally involves a simple blood screening that analyses the DNA, known as cell-free DNA(cf-DNA) to precisely estimate a baby’s risk for a variety of genetic disorders, such as Down syndrome.The gender of a fetus can also be determined using NIPT. Non-Invasive Prenatal Testing is used to identify the most common chromosome anomalies like Down Syndrome (Trisomy 21), Edwards Syndrome (Trisomy 18), and the Patau Syndrome (Trisomy 13).

Market Forecast Report:

Global Non-Invasive Prenatal Testing Market was worth USD 1.95 billion in 2018 and is projected to be growing at a CAGR of 15.6%, to touch USD 4.03 billion by 2023.

Market Drivers and Restraints:

The growth of the Global Non-Invasive Prenatal Testing Market is mainly driven by factors such as the introduction of newer and more advanced NIPT products, the feasibility and growing preference for non-invasive techniques over invasive ones, increasing risk of chromosomal abnormalities in babies with growing maternal age and favorable reimbursement for NIPT. Key companies are playing a major role I expanding the boundaries of cf-DNA studies with attempts being at identifying about 20,000 genetic feature through a single sample in a single reaction. The possibilities of false positives coupled with the lower clinical validity of particularly the microdeletion segment are among the major restraints of the market.

Market Segmentation:

The Global Non-Invasive Prenatal Testing Market is segmented based on Instruments, Method of Screening, Application, End User and geography. Based on Instruments, the market is divided into Ultrasound, NGS, PCR, and Microarray. Based on Method, the Non-Invasive Prenatal Testing Market is segmented into FCMB and cf-DNA. Further, by Application, the market is branched into Trisomy, Microdeletion, Genetics, and Rh factor. Based on the End User, it is categorized into Hospital and Diagnostic Labs.

Market Geographical Analysis:

The market has been geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America leads the market in 2016, with the U.S. accounting for a major share. North America’s lead is justified by the presence of high-end technology, it is a developed market combined with the growing incidence of genetic abnormalities.

Europe comes in second in terms of market share owing to the rising awareness and establishment of MIPT procedures. However, Asia-Pacific is estimated to grow at the highest CAGR during the forecast period majorly because of the presence of exponentially greater population numbers.

Market Key Players:

The Non-Invasive Prenatal Testing market is very much fragmented in nature with the presence of international and local players. The noticeable players in the market implement various strategies such as product launches, and approvals, product innovation, R&D investment for advancement in Non-Invasive Prenatal Testing, with acquisitions, and mergers as their developmental strategies to endure the competitive setting of the market. The key players in the Non-Invasive Prenatal Testing market are GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China)

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Instruments                               

                                5.1.1 Introduction           

                                5.1.2 PCR            

                                5.1.3 Ultrasound              

                                5.1.4 NGS           

                                5.1.5 Microarray              

                                5.1.6  Y-o-Y Growth Analysis, By Instruments     

                                5.1.7  Market Attractiveness Analysis, By Instruments   

                                5.1.8  Market Share Analysis, By Instruments     

                5.2 Method                       

                                5.2.1 Introduction           

                                5.2.2 FCMB        

                                5.2.3 Cell-Free DNA (cf-DNA)     

                                5.2.4 Y-o-Y Growth Analysis, By Method               

                                5.2.5 Market Attractiveness Analysis, By Method             

                                5.2.6 Market Share Analysis, By Method              

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Trisomy    

                                5.3.3 Microdeletion        

                                5.3.4 Genetics  

                                5.3.5 Rh factor  

                                5.3.6 Y-o-Y Growth Analysis, By Application         

                                5.3.7  Market Attractiveness Analysis, By Application      

                                5.3.8  Market Share Analysis, By Application       

                5.4 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospital    

                                5.4.3 Diagnostic Labs      

                                5.4.4 Y-o-Y Growth Analysis, By End User             

                                5.4.5  Market Attractiveness Analysis, By End User          

                                5.4.6  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Instruments

                                                6.1.3.3 By Method

                                                6.1.3.4 By Application

                                                6.1.3.5 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Instruments

                                                6.1.4.3 By Method

                                                6.1.4.4 By Application

                                                6.1.4.5 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Instruments

                                                6.1.5.3 By Method

                                                6.1.5.4 By Application

                                                6.1.5.5 By End User

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 GE Healthcare                           

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Koninklijke Philips N.V                           

                8.3 Thermo Fisher Scientific                        

                8.4 Hoffman-La Roche                  

                8.5 Pacific Biosciences of California                          

                8.6 PerkinElmer                               

                8.7 QIAGEN N.V                               

                8.8 Agilent Technologies                              

                8.9 Beijing Genomics Institute                   

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Non-Invasive Prenatal Testing Market By Region, From 2018-2023 ( USD Billion )
  2. Global Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  3. Global Ultrasound Market By Region, From 2018-2023 ( USD Billion )
  4. Global NGS Market By Region, From 2018-2023 ( USD Billion )
  5. Global PCR Market By Region, From 2018-2023 ( USD Billion )
  6. Global Microarray Market By Region, From 2018-2023 ( USD Billion )
  7. Global Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  8. Global FCMB Market By Region, From 2018-2023 ( USD Billion )
  9. Global cf-DNA Market By Region, From 2018-2023 ( USD Billion )
  10. Global Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  11. Global Trisomy Market By Region, From 2018-2023 ( USD Billion )
  12. Global Microdeletion Market By Region, From 2018-2023 ( USD Billion )
  13. Global Genetics Market By Region, From 2018-2023 ( USD Billion )
  14. Global Rh Factor Market By Region, From 2018-2023 ( USD Billion )
  15. Global Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  16. Global Hospital Market By Region, From 2018-2023 ( USD Billion )
  17. Global Diagnostic Labs Market By Region, From 2018-2023 ( USD Billion )
  18. North America Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  19. North America Ultrasound Market By Region, From 2018-2023 ( USD Billion )
  20. North America NGS Market By Region, From 2018-2023 ( USD Billion )
  21. North America PCR Market By Region, From 2018-2023 ( USD Billion )
  22. North America Microarray Market By Region, From 2018-2023 ( USD Billion )
  23. North America Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  24. North America FCMB Market By Region, From 2018-2023 ( USD Billion )
  25. North America cf-DNA Market By Region, From 2018-2023 ( USD Billion )
  26. North America Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  27. North America Trisomy Market By Region, From 2018-2023 ( USD Billion )
  28. North America Microdeletion Market By Region, From 2018-2023 ( USD Billion )
  29. North America Genetics Market By Region, From 2018-2023 ( USD Billion )
  30. North America Rh Factor Market By Region, From 2018-2023 ( USD Billion )
  31. North America Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  32. North America Hospital Market By Region, From 2018-2023 ( USD Billion )
  33. North America Diagnostic Labs Market By Region, From 2018-2023 ( USD Billion )
  34. United States Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  35. United States Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  36. United States Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  37. United States Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  38. Canada Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  39. Canada Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  40. Canada Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  41. Canada Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  42. Europe Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  43. Europe Ultrasound Market By Region, From 2018-2023 ( USD Billion )
  44. Europe NGS Market By Region, From 2018-2023 ( USD Billion )
  45. Europe PCR Market By Region, From 2018-2023 ( USD Billion )
  46. Europe Microarray Market By Region, From 2018-2023 ( USD Billion )
  47. Europe Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  48. Europe FCMB Market By Region, From 2018-2023 ( USD Billion )
  49. Europe cf-DNA Market By Region, From 2018-2023 ( USD Billion )
  50. Europe Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  51. Europe Trisomy Market By Region, From 2018-2023 ( USD Billion )
  52. Europe Microdeletion Market By Region, From 2018-2023 ( USD Billion )
  53. Europe Genetics Market By Region, From 2018-2023 ( USD Billion )
  54. Europe Rh Factor Market By Region, From 2018-2023 ( USD Billion )
  55. Europe Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  56. Europe Hospital Market By Region, From 2018-2023 ( USD Billion )
  57. Europe Diagnostic Labs Market By Region, From 2018-2023 ( USD Billion )
  58. U.K. Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  59. U.K. Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  60. U.K. Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  61. U.K. Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  62. Germany Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  63. Germany Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  64. Germany Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  65. Germany Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  66. France Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  67. France Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  68. France Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  69. France Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  70. Italy Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  71. Italy Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  72. Italy Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  73. Italy Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  74. Spain Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  75. Spain Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  76. Spain Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  77. Spain Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  78. Asia-Pacific Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  79. Asia-Pacific Ultrasound Market By Region, From 2018-2023 ( USD Billion )
  80. Asia-Pacific NGS Market By Region, From 2018-2023 ( USD Billion )
  81. Asia-Pacific PCR Market By Region, From 2018-2023 ( USD Billion )
  82. Asia-Pacific Microarray Market By Region, From 2018-2023 ( USD Billion )
  83. Asia-Pacific Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  84. Asia-Pacific FCMB Market By Region, From 2018-2023 ( USD Billion )
  85. Asia-Pacific cf-DNA Market By Region, From 2018-2023 ( USD Billion )
  86. Asia-Pacific Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  87. Asia-Pacific Trisomy Market By Region, From 2018-2023 ( USD Billion )
  88. Asia-Pacific Microdeletion Market By Region, From 2018-2023 ( USD Billion )
  89. Asia-Pacific Genetics Market By Region, From 2018-2023 ( USD Billion )
  90. Asia-Pacific Rh Factor Market By Region, From 2018-2023 ( USD Billion )
  91. Asia-Pacific Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  92. Asia-Pacific Hospital Market By Region, From 2018-2023 ( USD Billion )
  93. Asia-Pacific Diagnostic Labs Market By Region, From 2018-2023 ( USD Billion )
  94. Japan Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  95. Japan Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  96. Japan Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  97. Japan Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  98. China Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  99. China Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  100. China Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  101. China Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  102. India Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  103. India Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  104. India Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  105. India Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  106. Australia Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  107. Australia Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  108. Australia Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  109. Australia Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  110. South Korea Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  111. South Korea Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  112. South Korea Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  113. South Korea Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  114. Latin America Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  115. Latin America Ultrasound Market By Region, From 2018-2023 ( USD Billion )
  116. Latin America NGS Market By Region, From 2018-2023 ( USD Billion )
  117. Latin America PCR Market By Region, From 2018-2023 ( USD Billion )
  118. Latin America Microarray Market By Region, From 2018-2023 ( USD Billion )
  119. Latin America Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  120. Latin America FCMB Market By Region, From 2018-2023 ( USD Billion )
  121. Latin America cf-DNA Market By Region, From 2018-2023 ( USD Billion )
  122. Latin America Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  123. Latin America Trisomy Market By Region, From 2018-2023 ( USD Billion )
  124. Latin America Microdeletion Market By Region, From 2018-2023 ( USD Billion )
  125. Latin America Genetics Market By Region, From 2018-2023 ( USD Billion )
  126. Latin America Rh Factor Market By Region, From 2018-2023 ( USD Billion )
  127. Latin America Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  128. Latin America Hospital Market By Region, From 2018-2023 ( USD Billion )
  129. Latin America Diagnostic Labs Market By Region, From 2018-2023 ( USD Billion )
  130. Brazil Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  131. Brazil Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  132. Brazil Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  133. Brazil Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  134. Argentina Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  135. Argentina Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  136. Argentina Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  137. Argentina Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  138. Mexico Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  139. Mexico Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  140. Mexico Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  141. Mexico Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  142. Rest of Latin America Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  143. Rest of Latin America Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  144. Rest of Latin America Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  145. Rest of Latin America Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  146. Middle East & Africa Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  147. Middle East & Africa Ultrasound Market By Region, From 2018-2023 ( USD Billion )
  148. Middle East & Africa NGS Market By Region, From 2018-2023 ( USD Billion )
  149. Middle East & Africa PCR Market By Region, From 2018-2023 ( USD Billion )
  150. Middle East & Africa Microarray Market By Region, From 2018-2023 ( USD Billion )
  151. Middle East & Africa Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  152. Middle East & Africa FCMB Market By Region, From 2018-2023 ( USD Billion )
  153. Middle East & Africa cf-DNA Market By Region, From 2018-2023 ( USD Billion )
  154. Middle East & Africa Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  155. Middle East & Africa Trisomy Market By Region, From 2018-2023 ( USD Billion )
  156. Middle East & Africa Microdeletion Market By Region, From 2018-2023 ( USD Billion )
  157. Middle East & Africa Genetics Market By Region, From 2018-2023 ( USD Billion )
  158. Middle East & Africa Rh Factor Market By Region, From 2018-2023 ( USD Billion )
  159. Middle East & Africa Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  160. Middle East & Africa Hospital Market By Region, From 2018-2023 ( USD Billion )
  161. Middle East & Africa Diagnostic Labs Market By Region, From 2018-2023 ( USD Billion )
  162. Middle East Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  163. Middle East Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  164. Middle East Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  165. Middle East Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  166. Africa Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  167. Africa Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  168. Africa Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  169. Africa Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients

Research Areas